KOMO Biosciences, a developer of non-viral targeted insertion technologies, today announced that it has granted Syngenta, a world leader in agricultural innovation, a Research Evaluation License to ...

Picture this: You're signing a credit card receipt at the bank, using one of those pens attached to a short chain. As a left-handed person, you awkwardly ...

INSTALL results showed successful and safe non-viral insertion of large genetic payloads in the livers of mice when delivered by lipid nanoparticles (LNPs). In contrast, mice experienced fatal immune ...

Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution.

Risk stratification used a validated 5-year absolute risk calculator incorporating breast density, family history, biopsy history, race/ethnicity, and menopausal status, with reassessment every five ...

Couldn’t we use bacteria to break down plastic in the environment so it isn’t such an ecosystem hazard? -- Patricia S., via email ...

Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory ...

The world of ancient history is filled with captivating stories that have captured our imagination for generations. From lost ...

Direct engagement in research exposes students to a growth mindset and expands their possibilities of working with leading employers and attending top graduate and professional schools. The annual ...